Metraipolis › archive › dc_e84a2a08536d
Toxoplasma gondii as a drug for anti-tumor immunotherapy: mechanisms, challenges, and perspectives — Europe PMC PMID:41641877
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41641877
- DOI
- 10.1051/parasite/2026006
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T02:13:32.879Z
- SHA-256 of the archived text
142d4643e28aa8758113bc5f15baeb227d3d2d1a78ebd330e498911e7ca9ef6f- Stable URL of this page
https://metraipolis.com/documento/dc_e84a2a08536d
How to cite
Toxoplasma gondii as a drug for anti-tumor immunotherapy: mechanisms, challenges, and perspectives — Europe PMC PMID:41641877 — Europe PMC (en), https://europepmc.org/article/MED/41641877 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e84a2a08536d (Metraipolis archive dc_e84a2a08536d, sha256 142d4643e28aa8758113bc5f15baeb227d3d2d1a78ebd330e498911e7ca9ef6f)
BibTeX
@misc{dce84a2a08536d,
title = {Toxoplasma gondii as a drug for anti-tumor immunotherapy: mechanisms, challenges, and perspectives — Europe PMC PMID:41641877},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41641877},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e84a2a08536d; sha256 142d4643e28aa8758113bc5f15baeb227d3d2d1a78ebd330e498911e7ca9ef6f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41641877. Agents can read the archived copy with the MCP tool read_document.